Let’s clear a few things up

AngioScore

Business Problem:
Angioscore had significant clinical evidence to support their effective new type of stent. However, their efficacy message was getting overwhelmed by competitive sales messages.

183 Strategic Solution:
183 Designed an interactive collateral piece “Let’s Clear a Few Things Up,” that revealed the truth about Angioscuplt’s performance. The piece also allowed physicians to directly download the relevant studies to their phones during the sales call.